These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1800153)

  • 1. [The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials].
    Vorob'ev LP; Maev IV
    Farmakol Toksikol; 1991; 54(5):54-7. PubMed ID: 1800153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative evaluation of the hemodynamic effects of nitrosorbide, korinfar, obzidan and spesikor in blockade of the left branch of the bundle of His].
    Maev IV; V'iuchnova ES; Vorob'ev LP
    Eksp Klin Farmakol; 1993; 56(1):36-9. PubMed ID: 8324471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of nitrosorbide, korinfar, obzidan and spesikor on cardiovascular function in a right bundle of His block].
    Vorob'ev LP; Maev IV; V'iuchnova ES
    Ter Arkh; 1992; 64(12):83-7. PubMed ID: 1292142
    [No Abstract]   [Full Text] [Related]  

  • 5. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of nitrosorbide, corinfar and obsidan in preventing ischemia caused by the dipyridamole test].
    Furkalo NK; Lutaĭ MI; Simorot VN; Zaĭtseva VI
    Kardiologiia; 1987 Nov; 27(11):68-72. PubMed ID: 3437668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypertension with the calcium antagonist korinfar and its combination with obzidan].
    Shkhvatsabaia IK; Erina EV; Prokopova TN; Charyev KhE; D'iakonova EG
    Ter Arkh; 1986; 58(6):122-7. PubMed ID: 3764704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension].
    Wu XN
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325
    [No Abstract]   [Full Text] [Related]  

  • 11. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New trends in the treatment of hemodynamic disorders in liver cirrhosis].
    Vorob'ev LP; Maev IV
    Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of corinfar, nitrosorbide and apressin on external respiration and blood flow in chronic obstructive bronchitis].
    Vorob'ev LP; Maev IV
    Ross Med Zh; 1992; (1):40-1. PubMed ID: 1611269
    [No Abstract]   [Full Text] [Related]  

  • 15. Portal hemodynamics after meal in normal subjects and in patients with chronic liver disease studied by echo-Doppler flowmeter.
    Pugliese D; Ohnishi K; Tsunoda T; Sabba C; Albano O
    Am J Gastroenterol; 1987 Oct; 82(10):1052-6. PubMed ID: 2959148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension].
    Volkova LI
    Ter Arkh; 1989; 61(8):50-3. PubMed ID: 2588166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of central and porto-hepatic hemodynamics before the surgical treatment of patients with liver cirrhosis and portal hypertension].
    Eramishantsev AK; Gogichaĭshvili SSh; Lebezev VM; Kitsenko EA; Dolidze MA
    Klin Med (Mosk); 1991 Feb; 69(2):81-3. PubMed ID: 1875671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose-dependent acute effect and long-term modification by molsidomine of portal and cardiac hemodynamics in patients with liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():65-8, 76. PubMed ID: 7968910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.